Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06783751 · ClinicalTrials.gov registry record · NA

Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)

A NA study of Obesity and Gastroesophageal Reflux Disease, sponsored by University of California, Irvine.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
2
Study locations

NCT06783751 is a NA study of Obesity and Gastroesophageal Reflux Disease that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 44 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06783751, a NA study of Obesity and Gastroesophageal Reflux Disease, is actively recruiting participants, sponsored by University of California, Irvine.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
2
Study locations

Study Summary

This is a two-site randomized clinical trial aiming to test whether a modified investigational bariatric surgical procedure can improve gastroesophageal reflux disease (GERD) after sleeve gastrectomy.

Interventions

  • PROCEDURE Modified Vertical Sleeve Gastrectomy (mVSG)
  • PROCEDURE Conventional Vertical Sleeve Gastrectomy (cVSG)

Study Locations (2)

California

  • University of California, Irvine - Orange
  • University of California, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2025-03-21
Est. Completion 2027-07-31
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT06783751

The ClinicalTrials.gov registry entry for NCT06783751 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Modified Vertical Sleeve Gastrectomy (mVSG) is the first listed.

NCT06783751 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06783751 about?

NCT06783751 is a clinical study titled "Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)". This is a two-site randomized clinical trial aiming to test whether a modified investigational bariatric surgical procedure can improve gastroesophageal reflux disease (GERD) after sleeve gastrectomy.

What is the current status of trial NCT06783751?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2025-03-21. Estimated completion is 2027-07-31.

What conditions does trial NCT06783751 study?

This clinical trial studies the following conditions: Obesity, Gastroesophageal Reflux Disease, Bariatric Surgery, Sleeve Gastrectomy.

What interventions are being tested in trial NCT06783751?

The interventions under investigation include: Modified Vertical Sleeve Gastrectomy (mVSG) (PROCEDURE), Conventional Vertical Sleeve Gastrectomy (cVSG) (PROCEDURE).

Who is sponsoring clinical trial NCT06783751?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06783751 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.